Cryostat Microtome Equipment

Cryostat Microtome Equipment Market Outlook

The global Cryostat Microtome Equipment Market is expected to reach USD 800 million by 2035, growing at a CAGR of 6.5% from 2025 to 2035. This growth can be attributed to the increasing demand for precision in histological sample preparation, advancements in cryostat technology, and a rising number of research and clinical laboratories. Moreover, the growing prevalence of chronic diseases, which necessitate effective diagnostic methods, is accelerating the adoption of cryostat microtomes. The expansion of the pharmaceutical and biotechnology sectors is further propelling market growth, as these industries require sophisticated equipment for research and drug development purposes. Additionally, the trend towards automation in laboratories is expected to significantly impact the market, encouraging the production and use of fully automated cryostat microtomes.

Growth Factor of the Market

Several factors contribute to the growth of the Cryostat Microtome Equipment Market. Firstly, the increasing prevalence of diseases worldwide has led to a rise in the number of diagnostic procedures, thereby boosting the demand for efficient histology equipment. Moreover, advancements in cryostat technology, including the development of automated systems, have made these machines more user-friendly and efficient, further increasing their adoption in laboratories. The growing investment in research and development by pharmaceutical and biotechnology companies is also a significant driver of market growth, as these organizations require precise and reliable equipment for their experimental processes. Furthermore, the rising trend of personalized medicine necessitates accurate tissue analysis, which in turn drives the demand for cryostat microtomes. Lastly, the expansion of healthcare infrastructure in emerging economies is expected to provide new opportunities for market players.

Key Highlights of the Market

• The Cryostat Microtome Equipment Market is projected to grow at a CAGR of 6.5% from 2025 to 2035.
• Increased R&D spending in the pharmaceutical and biotechnology sectors is driving market expansion.
• Automated cryostat microtomes are gaining traction due to their operational efficiency.
• The rising prevalence of chronic diseases is boosting the demand for diagnostic tools.
• Emerging economies are experiencing rapid healthcare infrastructure development, creating new market opportunities.

By Product Type

Benchtop Cryostat Microtome:

Benchtop cryostat microtomes are compact devices designed for efficient specimen preparation in smaller laboratories. They offer a range of features including adjustable temperature settings and user-friendly interfaces. Their design allows for mobility and ease of use, making them a popular choice among research institutions and clinical laboratories with limited space. The increasing need for reliable and accurate tissue sectioning in these environments contributes significantly to the demand for benchtop models, as they strike a balance between functionality and size. Furthermore, advancements in technology continue to enhance the performance of benchtop cryostats, allowing them to maintain the required low temperatures, which is critical for preserving the integrity of biological samples.

Floor Standing Cryostat Microtome:

Floor standing cryostat microtomes are designed for high-throughput laboratories, offering larger capacity and advanced features. They are capable of handling a greater volume of samples and are equipped with sophisticated temperature control systems to ensure optimal sample preservation. These models are often utilized in hospital pathology departments and research facilities where tissue samples are prepared in bulk. The demand for floor standing cryostats is rising due to their robustness and efficiency in managing multiple samples, which is critical in high-pressure environments. Additionally, the integration of automation features allows for seamless operation, reducing human error and optimizing workflow.

Portable Cryostat Microtome:

Portable cryostat microtomes are specifically designed for fieldwork or remote applications. They are lightweight and compact, making them ideal for use in various settings outside of traditional laboratories. Their portability allows researchers to conduct on-site sample preparation, which is particularly useful in veterinary and environmental research. The rise in studies requiring immediate analysis of samples collected from diverse locations is driving the demand for portable models. Additionally, advancements in battery technology have made these devices more efficient and easier to use in the field, contributing to their growing popularity.

Semi-Automated Cryostat Microtome:

Semi-automated cryostat microtomes offer a blend of manual and automated functionalities, providing flexibility in sample preparation. These devices are equipped with features that allow for manual adjustments while incorporating automated functions to enhance precision and repeatability. The increasing preference for semi-automated systems is attributed to their cost-effectiveness and ability to cater to both routine and complex sample preparation tasks. Research laboratories particularly favor these models as they provide the necessary control over the process while minimizing the chances of human error, resulting in high-quality tissue sections.

Fully Automated Cryostat Microtome:

Fully automated cryostat microtomes represent the pinnacle of technology in the preparation of histological samples, offering high efficiency and precision. These advanced systems are designed to minimize manual intervention, thereby reducing the risk of contamination and improving reproducibility in results. They are equipped with sophisticated software that allows for various programmable settings, ensuring consistent performance across multiple runs. The growing trend towards automation in laboratories and the demand for high-throughput processing capabilities are driving the adoption of fully automated cryostats. They are particularly valuable in high-volume settings where accuracy and efficiency are paramount, such as large research institutions and hospital laboratories.

By Application

Clinical Diagnosis:

In the realm of clinical diagnosis, cryostat microtomes play a vital role in the preparation of tissue samples for examination under a microscope. Their capability to produce thin, precise sections of frozen tissue is essential in diagnosing various medical conditions, including cancers and infectious diseases. The increasing focus on early diagnosis and the rising number of diagnostic procedures are significantly driving the adoption of cryostat microtomes in clinical settings. Moreover, advancements in imaging techniques and an increase in the prevalence of chronic diseases have further boosted the demand for these devices, as accurate tissue analysis is crucial for treatment planning and patient management.

Research Laboratories:

Research laboratories utilize cryostat microtomes extensively for various applications, including the study of tissue morphology and the development of new therapeutic strategies. The need for precise and reproducible sample preparation is critical in research, as it directly affects the quality of the results obtained. The continuous advancement in research methodologies and an increasing focus on understanding cellular mechanisms are driving the demand for advanced cryostat microtomes. Furthermore, the rise in collaborative research initiatives across various scientific disciplines is promoting the use of these devices, as they facilitate high-quality tissue analysis essential for groundbreaking discoveries.

Pharmaceutical & Biotechnology Companies:

Within the pharmaceutical and biotechnology sectors, cryostat microtomes are essential in the drug development process, particularly in the evaluation of new therapeutics. These companies rely on precise tissue sectioning for toxicology studies and efficacy evaluation. The increasing investments in R&D by pharmaceutical firms are significantly boosting the demand for advanced cryostat microtomes that can provide high-quality samples for analysis. Additionally, the growth of personalized medicine and the need for effective drug delivery systems further drive the need for precise tissue analysis, reinforcing the role of cryostats in modern pharmaceutical research.

Others:

The "Others" category encompasses additional applications of cryostat microtomes, including educational institutions and specialized research centers. In educational settings, these devices are vital tools for teaching histology and pathology, allowing students to gain hands-on experience in sample preparation. Furthermore, specialized research centers focusing on unique biological studies rely on cryostat microtomes for high-quality tissue analysis. The growing recognition of the importance of histological techniques in various scientific fields is contributing to the expansion of this market segment.

By Distribution Channel

Direct Sales:

Direct sales channels are crucial for the distribution of cryostat microtomes, as they facilitate direct interaction between manufacturers and end-users. This approach allows companies to provide tailored solutions based on specific customer needs and preferences. Direct sales provide a significant advantage in terms of customer service and support, as manufacturers can offer training and maintenance services directly to users. This personalized approach enhances customer satisfaction and builds long-term relationships. Furthermore, direct sales are increasingly becoming a popular choice for acquiring high-end laboratory equipment, leading to better market penetration.

Distributor Sales:

Distributor sales account for a substantial portion of the cryostat microtome market, particularly in regions where manufacturers may not have a direct presence. Distributors play a pivotal role in reaching a wider customer base by leveraging their established networks in the healthcare and laboratory sectors. They often provide comprehensive support, including after-sales services, training, and maintenance, which enhances the overall customer experience. Additionally, distributors can offer multiple brands and models, giving customers a broader range of options to choose from based on their requirements. The growing trend towards outsourcing procurement processes is further solidifying the importance of distributor sales in this market.

By Technology Type

Manual Cryostat Microtome:

Manual cryostat microtomes are traditional models that require operator intervention for sample preparation. Despite the rise of automated systems, manual cryostats remain popular due to their lower cost and simplicity. Many smaller laboratories, educational institutions, and research centers still rely on manual cryostats for their routine procedures. The hands-on operation allows for greater flexibility in adjusting settings, which can be beneficial for specific applications. Manual cryostat microtomes are particularly valued for their reliability and ease of maintenance, making them a staple in laboratories where budget constraints are a concern.

Semi-Automated Cryostat Microtome:

Semi-automated cryostat microtomes incorporate both manual and automated functionalities, providing users with the best of both worlds. These systems allow operators to perform manual adjustments while benefiting from automated features that enhance precision and reproducibility. This hybrid technology is particularly appealing to laboratories that require flexibility and efficiency in their sample preparation processes. The growing preference for semi-automated systems can be attributed to their ability to reduce human error while maintaining the operator's control over critical parameters. This adaptability makes them an excellent choice for research-focused laboratories that handle a variety of sample types.

Fully Automated Cryostat Microtome:

Fully automated cryostat microtomes represent the latest innovation in tissue preparation technology. These sophisticated machines are designed to minimize manual intervention, allowing for higher throughput and consistent results. Equipped with advanced software and control systems, fully automated cryostats can precisely manage all stages of sample preparation, significantly reducing the risk of contamination. The demand for these systems is on the rise as laboratories increasingly favor automation to improve efficiency and accuracy. Fully automated cryostat microtomes are especially valuable in high-volume settings, where the need for rapid and reliable sample analysis is paramount.

By User

Hospitals & Clinics:

Hospitals and clinics are significant end-users of cryostat microtomes, as they require reliable and efficient tools for histopathology. The demand for these devices in clinical settings is driven by the increasing need for rapid and accurate diagnostic procedures. Pathology departments in hospitals utilize cryostat microtomes to prepare frozen sections for immediate examination, which is crucial for timely treatment decisions. The growing prevalence of chronic diseases and the rising number of surgical procedures further accelerate the demand for cryostat microtomes in these settings. Additionally, advancements in technology are enabling hospitals to adopt more sophisticated cryostat systems to enhance their diagnostic capabilities.

Research Institutes:

Research institutes are vital users of cryostat microtomes, utilizing these devices for a variety of scientific studies, including cancer research and developmental biology. The precision and quality of sample preparation are critical in research settings, making cryostat microtomes indispensable tools in laboratories. The increasing focus on innovative research and the quest for new therapeutic solutions are driving the demand for advanced cryostat technology in these institutions. As research initiatives expand and funding for scientific studies grows, the need for reliable and efficient tissue preparation methods remains a priority. Research institutes often require high-throughput capabilities and precision, further reinforcing their reliance on modern cryostat microtomes.

Diagnostic Centers:

Diagnostic centers play a crucial role in the healthcare system by providing essential testing services, and cryostat microtomes are an integral part of their operations. These centers utilize cryostats to prepare tissue samples for histopathological examination, providing timely and accurate diagnoses. The increasing emphasis on early detection of diseases, particularly cancers, is driving the demand for cryostat microtomes in diagnostic settings. Moreover, advancements in diagnostic technologies and an expanding patient population contribute to the growing need for efficient and high-quality tissue preparation. As diagnostic centers continue to evolve and expand their services, the adoption of advanced cryostat microtomes is expected to rise.

Others:

The "Others" category encompasses various users of cryostat microtomes, including educational institutions and specialized research facilities. Educational institutions utilize cryostat microtomes to teach students about histology and pathology, providing them with hands-on experience in tissue preparation techniques. Additionally, specialized research facilities may require cryostat microtomes for specific studies that necessitate precise sample preparation. As the importance of histological techniques continues to gain recognition across diverse scientific fields, the demand for cryostat microtomes from these users is poised to grow significantly.

By Region

The regional analysis of the Cryostat Microtome Equipment Market reveals distinct growth patterns across different areas. North America stands out as a leading market, driven by the presence of advanced healthcare infrastructure and a high concentration of research institutions. The region is estimated to account for approximately 35% of the global market share, with a significant CAGR of 6.8% projected through 2035. This growth is supported by an increase in research funding and advancements in medical technology, which are further propelling the use of cryostat microtomes in clinical and research settings. Moreover, the growing emphasis on personalized medicine and early disease detection is expected to drive the demand for cryostat microtomes in hospitals and laboratories across North America.

Europe is also witnessing a robust growth trajectory in the cryostat microtome market, with a projected market share of around 30%. The region is characterized by a strong focus on research and development within the pharmaceutical and biotechnology sectors, which is driving the demand for advanced cryostat systems. Furthermore, the increasing prevalence of chronic diseases in Europe necessitates effective diagnostic tools, further enhancing the market potential. The Asia Pacific region is anticipated to experience the highest CAGR of 7.2% through 2035, fueled by rapid advancements in healthcare infrastructure and rising investments in research initiatives. Emerging economies in this region, such as India and China, are actively enhancing their laboratory capabilities, thereby creating significant opportunities for cryostat microtome manufacturers.

Opportunities

The Cryostat Microtome Equipment Market is poised to benefit from several emerging opportunities that can accelerate its growth trajectory. One of the most significant opportunities lies in the increasing demand for automated solutions in laboratories. As laboratories strive for efficiency and accuracy, the shift towards automation presents a lucrative avenue for market players to introduce advanced fully automated cryostat systems. Furthermore, the rise in personalized medicine is creating a growing need for precise tissue analysis, which can only be achieved through the utilization of high-quality cryostat microtomes. This trend is particularly relevant in the pharmaceutical and biotechnology sectors, where accurate tissue preparation is critical for drug development and efficacy evaluation.

Another notable opportunity exists in the expansion of healthcare infrastructure in emerging economies. As countries like India, China, and Brazil invest in upgrading their healthcare facilities, the demand for advanced laboratory equipment, including cryostat microtomes, is expected to surge. Market players can capitalize on this trend by establishing partnerships with local distributors and offering customized solutions tailored to the specific needs of these markets. Additionally, the growing emphasis on research in various scientific fields is driving the need for quality sample preparation methods, further enhancing the market opportunities for cryostat microtome manufacturers. By leveraging these opportunities, businesses can position themselves for significant growth in the coming years.

Threats

Despite the promising growth prospects in the Cryostat Microtome Equipment Market, several threats could hinder its expansion. One of the primary concerns is the intense competition among established players and new entrants in the market. This competitive landscape may lead to price wars, resulting in reduced profit margins for manufacturers. Furthermore, rapid technological advancements require companies to continually innovate and enhance their product offerings, which can strain resources and increase operational costs. Additionally, the presence of alternative tissue preparation methods, such as paraffin embedding, may pose a threat to the growth of the cryostat microtome market as some laboratories may opt for these traditional techniques.

Another significant threat arises from regulatory challenges, as manufacturers must adhere to stringent guidelines and standards set forth by health authorities in different regions. Compliance with these regulations can be time-consuming and costly, potentially affecting the speed of product development and market entry. Additionally, global economic uncertainties and fluctuations in currency exchange rates can affect the purchasing power of end-users, leading to a decline in demand for high-end laboratory equipment. Addressing these challenges will be crucial for market participants to sustain their growth and profitability in a competitive environment.

Competitor Outlook

• Leica Biosystems
• Thermo Fisher Scientific
• Sakura Finetek
• Histo-Line Laboratories
• Microm International
• Jung (Leica)
• Histo-Tec
• RMC Boeckeler
• Kryo 1000
• Bright Instruments
• Pathology Devices
• Fisher Scientific
• Abcam
• PerkinElmer
• CellPath

The Cryostat Microtome Equipment Market is characterized by a diverse competitive landscape, comprising both established players and emerging companies. Major manufacturers like Leica Biosystems and Thermo Fisher Scientific dominate the market, offering a range of advanced cryostat systems equipped with cutting-edge technology. These companies have established strong distribution networks and service capabilities, allowing them to meet the diverse needs of their customers effectively. Furthermore, continuous investment in research and development enables these players to innovate and introduce state-of-the-art cryostat microtomes that enhance efficiency and precision in sample preparation.

Emerging players in the market, such as Histo-Line Laboratories and RMC Boeckeler, are also gaining traction by focusing on niche applications and providing specialized solutions tailored to specific sectors, such as pharmaceutical research and clinical diagnostics. These companies often emphasize customer service and support, setting themselves apart from larger competitors. The growing trend of collaboration among market players, including partnerships and acquisitions, is also shaping the competitive landscape, as companies seek to expand their product offerings and market reach.

As the demand for cryostat microtomes continues to grow, key players are likely to increase their investment in technological advancements to stay ahead of the competition. Companies like Sakura Finetek and Bright Instruments are focusing on automation and digitalization to enhance their product lines, catering to the evolving needs of laboratories. Additionally, strategic collaborations with research institutions and healthcare providers can facilitate the development of innovative solutions, further solidifying their market presence. Overall, the competitive landscape of the Cryostat Microtome Equipment Market is dynamic, with companies continuously adapting to market trends and customer demands to maintain their competitive edge.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Abcam
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 CellPath
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Histo-Tec
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Kryo 1000
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 PerkinElmer
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Jung (Leica)
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 RMC Boeckeler
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Sakura Finetek
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Leica Biosystems
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Fisher Scientific
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Pathology Devices
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Bright Instruments
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Microm International
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Histo-Line Laboratories
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Thermo Fisher Scientific
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Cryostat Microtome Equipment Market, By User
    • 6.1.1 Hospitals & Clinics
    • 6.1.2 Research Institutes
    • 6.1.3 Diagnostic Centers
    • 6.1.4 Others
  • 6.2 Cryostat Microtome Equipment Market, By Application
    • 6.2.1 Clinical Diagnosis
    • 6.2.2 Research Laboratories
    • 6.2.3 Pharmaceutical & Biotechnology Companies
    • 6.2.4 Others
  • 6.3 Cryostat Microtome Equipment Market, By Product Type
    • 6.3.1 Benchtop Cryostat Microtome
    • 6.3.2 Floor Standing Cryostat Microtome
    • 6.3.3 Portable Cryostat Microtome
    • 6.3.4 Semi-Automated Cryostat Microtome
    • 6.3.5 Fully Automated Cryostat Microtome
  • 6.4 Cryostat Microtome Equipment Market, By Technology Type
    • 6.4.1 Manual Cryostat Microtome
    • 6.4.2 Semi-Automated Cryostat Microtome
    • 6.4.3 Fully Automated Cryostat Microtome
  • 6.5 Cryostat Microtome Equipment Market, By Distribution Channel
    • 6.5.1 Direct Sales
    • 6.5.2 Distributor Sales

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Cryostat Microtome Equipment Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Cryostat Microtome Equipment market is categorized based on

By Product Type

• Benchtop Cryostat Microtome
• Floor Standing Cryostat Microtome
• Portable Cryostat Microtome
• Semi-Automated Cryostat Microtome
• Fully Automated Cryostat Microtome

By Application

• Clinical Diagnosis
• Research Laboratories
• Pharmaceutical & Biotechnology Companies
• Others

By Distribution Channel

• Direct Sales
• Distributor Sales

By Technology Type

• Manual Cryostat Microtome
• Semi-Automated Cryostat Microtome
• Fully Automated Cryostat Microtome

By User

• Hospitals & Clinics
• Research Institutes
• Diagnostic Centers
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Leica Biosystems
• Thermo Fisher Scientific
• Sakura Finetek
• Histo-Line Laboratories
• Microm International
• Jung (Leica)
• Histo-Tec
• RMC Boeckeler
• Kryo 1000
• Bright Instruments
• Pathology Devices
• Fisher Scientific
• Abcam
• PerkinElmer
• CellPath